Cell lines representing all subtypes of breast cancer (ER+, HER2+, and TNBC) and serous and endometrioid endometrial cancer were sensitive to ONC201-mediated growth inhibition (Supplementary Table 1). Here, ERBB2 is linked to breast cancer.